175 related articles for article (PubMed ID: 29526036)
1. Differential blood cellular profile in patients with moderate-to-severe psoriasis treated with classical systemic therapies: a step forward in personalized medicine.
Hernández-Breijo B; Jurado T; Rodríguez-Martín E; Martínez-Feito A; Plasencia-Rodríguez C; Balsa A; Alonso-Pacheco ML; Villar LM; Herranz-Pinto P; Pascual-Salcedo D
Br J Dermatol; 2018 Sep; 179(3):765-766. PubMed ID: 29526036
[No Abstract] [Full Text] [Related]
2. Brodalumab in the treatment of moderate to severe psoriasis in patients when previous anti-interleukin 17A therapies have failed.
Kimmel G; Chima M; Kim HJ; Bares J; Yao CJ; Singer G; Kim SJ; Bagel J; Lebwohl M
J Am Acad Dermatol; 2019 Sep; 81(3):857-859. PubMed ID: 31078609
[No Abstract] [Full Text] [Related]
3. Effectiveness of sequential use of biologics in the treatment of moderate to severe psoriasis in real world Canadian academic clinical practice: A cohort study.
Qiang JK; Shahbaz A; Kim W; Marinas J; Greaves S; Yeung J
J Am Acad Dermatol; 2016 Jan; 74(1):176-7. PubMed ID: 26702799
[No Abstract] [Full Text] [Related]
4. Herpes Zoster Rates in a Large Cohort of Patients With Systemically Treated Psoriasis.
Levandoski KA; Quesenberry CP; Tsai AL; Asgari MM
JAMA Dermatol; 2018 Feb; 154(2):218-219. PubMed ID: 29261840
[TBL] [Abstract][Full Text] [Related]
5. Review of safety and efficacy of approved systemic psoriasis therapies.
Kaushik SB; Lebwohl MG
Int J Dermatol; 2019 Jun; 58(6):649-658. PubMed ID: 30246393
[TBL] [Abstract][Full Text] [Related]
6. Switching biologics in severe pediatric psoriasis: a retrospective analysis.
Ramos Pinheiro R; Diamantino F; Cabete J; Brasileiro A; Baptista J; Lopes MJP
Int J Dermatol; 2017 Dec; 56(12):1461-1464. PubMed ID: 28960270
[No Abstract] [Full Text] [Related]
7. Proposal for long-term protocols after Psoriasis Area and Severity Index clear with initial biologic therapy: Happily ever after with or without biologics in psoriasis therapy.
Sano S
J Dermatol; 2017 Oct; 44(10):e234-e235. PubMed ID: 28623843
[No Abstract] [Full Text] [Related]
8. Histone modifications associated with biological drug response in moderate-to-severe psoriasis.
Ovejero-Benito MC; Reolid A; Sánchez-Jiménez P; Saiz-Rodríguez M; Muñoz-Aceituno E; Llamas-Velasco M; Martín-Vilchez S; Cabaleiro T; Román M; Ochoa D; Daudén E; Abad-Santos F
Exp Dermatol; 2018 Dec; 27(12):1361-1371. PubMed ID: 30260532
[TBL] [Abstract][Full Text] [Related]
9. Serum fatty acid-binding protein 4 level is inversely correlated with serum thymus and activation-regulated chemokine level in psoriatic patients achieving clear skin by biologics.
Honma M; Shibuya T; Iinuma S; Ishida-Yamamoto A
J Dermatol; 2019 Apr; 46(4):e116-e117. PubMed ID: 30216494
[No Abstract] [Full Text] [Related]
10. Adalimumab in the treatment of moderate-to-severe chronic plaque psoriasis in patients switching from other biologics.
Sator P; Richter L; Saxinger W; Vasiljevic M; Stingl G
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1742-9. PubMed ID: 25665143
[TBL] [Abstract][Full Text] [Related]
11. The role of biologics in the treatment of moderate-to-severe plaque psoriasis.
Puig L
G Ital Dermatol Venereol; 2017 Feb; 152(1):28-35. PubMed ID: 27627100
[TBL] [Abstract][Full Text] [Related]
12. Studying the effect of systemic and biological drugs on intima-media thickness in patients suffering from moderate and severe psoriasis.
Martinez-Lopez A; Blasco-Morente G; Perez-Lopez I; Tercedor-Sanchez J; Arias-Santiago S
J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1492-1498. PubMed ID: 29405437
[TBL] [Abstract][Full Text] [Related]
13. Effect of mycophenolate mofetil therapy on the phenotypic profile of peripheral blood leukocyte populations in psoriatic patients.
Daudén E; Pedraz J; Pérez-Gala S; Muñoz C; Vitón M; Onate MJ; García-Díez A
Eur J Dermatol; 2010; 20(2):233-4. PubMed ID: 20007061
[No Abstract] [Full Text] [Related]
14. Sustained Psoriasis Area and Severity Index, Dermatology Life Quality Index and EuroQol-5D response of biological treatment in psoriasis: 10 years of real-world data in the Swedish National Psoriasis Register.
Hjalte F; Carlsson KS; Schmitt-Egenolf M
Br J Dermatol; 2018 Jan; 178(1):245-252. PubMed ID: 28644904
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of topical antipsoriatic treatments, systemic treatment and biologics: is severity assessment beyond Psoriasis Area and Severity Index a necessity?
van de Kerkhof PC; Mrowietz U; Segaert S; Kragballe K
Br J Dermatol; 2007 Apr; 156(4):771-2. PubMed ID: 17263798
[No Abstract] [Full Text] [Related]
16. Switching of biologics in psoriasis: Reasons and results.
Honda H; Umezawa Y; Kikuchi S; Yanaba K; Fukuchi O; Ito T; Nobeyama Y; Asahina A; Nakagawa H
J Dermatol; 2017 Sep; 44(9):1015-1019. PubMed ID: 28488283
[TBL] [Abstract][Full Text] [Related]
17. Combination Use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis Registry.
Bonomo L; Abittan BJ; Hashim PW; Karki C; Mason M; Lebwohl M
J Drugs Dermatol; 2019 Aug; 18(8):731-740. PubMed ID: 31424705
[TBL] [Abstract][Full Text] [Related]
18. Secukinumab re-initiation achieves regain of high response levels in patients who interrupt treatment for moderate to severe plaque psoriasis.
Blauvelt A; Reich K; Warren RB; Szepietowski JC; Sigurgeirsson B; Tyring SK; Messina I; Bhosekar V; Oliver J; Papavassilis C; Frueh J; Langley RGB
Br J Dermatol; 2017 Sep; 177(3):879-881. PubMed ID: 28498514
[No Abstract] [Full Text] [Related]
19. Efficacy and safety of systemic treatments for psoriasis in elderly patients.
Piaserico S; Conti A; Lo Console F; De Simone C; Prestinari F; Mazzotta A; Gualdi G; Guarneri C; Borsari S; Cassano N
Acta Derm Venereol; 2014 May; 94(3):293-7. PubMed ID: 24158307
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate markedly reduces the expression of vascular E-selectin, cutaneous lymphocyte-associated antigen and the numbers of mononuclear leucocytes in psoriatic skin.
Sigmundsdottir H; Johnston A; Gudjonsson JE; Bjarnason B; Valdimarsson H
Exp Dermatol; 2004 Jul; 13(7):426-34. PubMed ID: 15217363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
